{
  "pmcid": "11490177",
  "sha256": "8c75819f5766ec678b19cecb09bdcea2edd49f21ada74aa26fa4c8b85abaeee4",
  "timestamp_utc": "2025-11-09T22:04:17.141142+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 16.34,
    "reading_ease": 10.566666666666691,
    "word_count": 220
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Tranexamic Acid in Major Abdominal Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "multicenter, double-blind, placebo-controlled, randomised superiority trial involves 850 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients aged 18 years or older undergoing elective esophagectomy, gastrectomy, colectomy, rectal resection, pancreatic resection, or hepatectomy across eleven academic hospitals in Germany"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 1:1 to receive either TXA (1000 mg bolus before incision, 125 mg/h until closure) or placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "Positive results would support routine TXA use in major abdominal surgery"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome is the need for transfusion of at least one unit of PRBCs, measured intra- or postoperatively"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation is computer-generated with allocation concealment via sealed envelopes"
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding includes patients, clinicians, and outcome assessors"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Recruitment began on June 17, 2024, with completion expected by November 2025"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events will be monitored"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "trial registration EU CT Nr: 2023–509970-43–01, NCT06414031"
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding is provided by institutional grants"
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}